Christopher Grange

Christopher Grange has extensive experience in research and development, particularly in the field of immunohistochemistry. Since October 2016, Christopher has held multiple leadership roles at Cell Signaling Technology, including Senior Group Leader and Group Leader of Immunohistochemistry, demonstrating a strong progression from Senior Research Associate to R&D Supervisor. Prior to this, Christopher worked at Jounce Therapeutics, Inc. as a Senior Research Associate and at Cell Signaling Technology as a Research Associate. Additional experience includes a position as a Quality Control Analyst at Lonza. Christopher graduated from the University of Massachusetts Lowell.